Report Overview:
Pharmaceutical extract is a preparation of pharmaceutical drugs that involves the extraction of active compounds from plants or animal tissue using solvents. The crude extract is the freshly obtained product acquired from the extraction process of the natural substance. Extraction methods include solvent extraction, distillation method, pressing and sublimation according to the extraction principle. Plant extracts are complex matrices with a rich composition of specialized metabolites that exhibit many different biological activities and are therefore used in the prevention and treatment of various diseases and disorders.
This report provides a deep insight into the global Pharmaceutical Plant Extracts market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
Market Value:
The global Pharmaceutical Plant Extracts market size was estimated at USD 5752 million in 2024 and is projected to reach USD 8179.92 million by 2032, exhibiting a CAGR of 4.50% during the forecast period.
North America Pharmaceutical Plant Extracts market size was estimated at USD 1616.66 million in 2024, at a CAGR of 3.86% during the forecast period of 2025 through 2032.
CAGR of 4.50%
(2024 – 2030)
By Types:
•Non-standardized Extracts
•Standardized Extracts
By Applications: Medicine
Key players include:
•Indena
•Network
•Schwabe
•Pharmachem
•Naturex
•Ipsen
•Provital Group
•Bioforce
•Including or Excluding key companies relevant to your analysis.
